NCT07446088 Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation
| NCT ID | NCT07446088 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ceragem Clinical Inc. |
| Condition | Improving Blood Circulation |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-12-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a single-center, open-label, exploratory clinical trial to evaluate the safety and efficacy of a statics electricity generator for improving blood circulation.
Eligibility Criteria
Inclusion Criteria: * Adults aged between 19 and 65 years * Individuals with a BMI of 30.0 kg/m² or less * Individuals without abnormal findings on hematology tests (CBC) Exclusion Criteria: * Patients with uncontrolled hypertension despite medication (defined as systolic blood pressure ≥150 mmHg or diastolic blood pressure ≥100 mmHg measured at rest) * Patients with medical conditions requiring the use of assistive devices (e.g., pacemaker, artificial joint, stent, prosthesis, etc.) * Patients with seizure disorders or a history of loss of consciousness (e.g., epilepsy, acute febrile convulsions such as those associated with severe fever, etc.), or those at high risk of electric shock due to such conditions * Patients with ventricular arrhythmias (e.g., ventricular tachycardia, history of coronary artery bypass surgery, etc.) and patients with neurological disorders (e.g., diabetic neuropathy, etc.)
Contact & Investigator
Kwang Yong Shim, MD
PRINCIPAL INVESTIGATOR
Wonju Severance Christian Hospital
Frequently Asked Questions
Who can join the NCT07446088 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 65 Years, studying Improving Blood Circulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07446088 currently recruiting?
Yes, NCT07446088 is actively recruiting participants. Contact the research team at mbshin94@ceragem.com for enrollment information.
Where is the NCT07446088 trial being conducted?
This trial is being conducted at Wŏnju, South Korea.
Who is sponsoring the NCT07446088 clinical trial?
NCT07446088 is sponsored by Ceragem Clinical Inc.. The principal investigator is Kwang Yong Shim, MD at Wonju Severance Christian Hospital. The trial plans to enroll 40 participants.